Oral probiotics vs standard antimicrobials : In high risk pregnant women with bacterial vaginosis
Not Applicable
- Conditions
- Health Condition 1: O099- Supervision of high risk pregnancy, unspecified
- Registration Number
- CTRI/2023/02/049462
- Lead Sponsor
- Dr Pooja Adiga
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Symptomatic antenatal women diagnosed to have bacterial and who are at high risk for preterm delivery such as
previous H/O spontaneous preterm delivery , h/o preterm prelabor rupture of
membranes , h/o chorioamnionitis, h/o second trimester spontaneous abortions
Precious pregnancy
Women with short cervix
Multiple pregnancy
Diabetes mellitus in pregnancy
Exclusion Criteria
Immunocompromised individuals
Those who do not want to be part of the study
Women with uterine anomalies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the vaginal microbioflora, before and after treatment <br/ ><br>with oral probiotics along with the standard vaginal antimicrobials, among symptomatic <br/ ><br>high-risk pregnant women diagnosed to have bacterial vaginosis at 12- 22 weeks of <br/ ><br>pregnancy.Timepoint: 8 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method Comparison of gestational age at delivery, proportion of preterm birthTimepoint: post delivery